Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Veterinary Biologics Market CAGR Outlook And Future Development
The veterinary biologics market size has seen robust growth in recent years. Its valuation is expected to rise from $13.61 billion in 2025 to $14.61 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.3%. The expansion observed historically is attributed to the increasing prevalence of livestock diseases, a rise in the companion animal population, advancements in vaccine development, increased government funding for veterinary research, and the ongoing expansion of veterinary healthcare infrastructure.
The veterinary biologics market is anticipated to experience substantial growth over the next few years. It is projected to expand to $20.03 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.2%. This market expansion in the upcoming period is attributable to technological advancements in biologics, the rising adoption of precision medicine for animals, an increase in global pet ownership, growing public awareness of zoonotic diseases, and the expanding veterinary diagnostics sector. Significant trends identified for the forecast period include a stronger focus on preventive animal healthcare, the increasing utilization of rapid diagnostic solutions, the expansion of biologics for companion animals, the integration of immunomodulators into veterinary treatments, and a growing demand for solutions in livestock disease management.
Get A Free Sample Report With In-Depth Market Insights:
Veterinary Biologics Market Growth Catalysts And Demand Drivers
The rising trend of pet ownership is anticipated to fuel expansion within the veterinary biologics market. Pet adoption involves assuming responsibility for a domesticated animal, frequently from a shelter or rescue group, to offer a lasting and nurturing home. This increase in pet adoptions is largely driven by a greater understanding of animal welfare, as individuals increasingly acknowledge the advantages of welcoming rescued animals into their homes, preferring adoption over purchasing new pets. Veterinary biologics play a crucial role by preventing various infectious diseases in pets, conferring immunity, managing zoonotic diseases, extending lifespan and enhancing quality of life, lowering veterinary healthcare expenditures, improving reproductive health in pets, and delivering more precise and tailored treatment solutions. For example, data from the American Pet Products Association, a US-based non-profit organization, indicated that in March 2025, ninety-four (94) million U.S. households owned at least one pet, an increase from eighty-two (82) million in 2023. Consequently, the growing rate of pet adoption is a significant impetus behind the growth of the veterinary biologics market.
Veterinary Biologics Market Segments: Where Is Growth Concentrated?
The veterinary biologics market covered in this report is segmented –
1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products
2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Disease Types
3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels
4) By Application: Production Animal, Companion Animal
Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines
2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits
3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants
4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums
5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids
Veterinary Biologics Market Trends Shaping Long-Term Demand
Leading firms within the veterinary biologics market are prioritizing the creation of innovative biologics, including vaccines, to improve animal well-being and avert diseases. A vaccine functions by stimulating the immune system to identify and combat specific disease-causing agents, thereby preventing contagious illnesses through induced immunity. As an illustration, Merck Animal Health, a global animal health firm based in the US, introduced an experimental autogenous vaccine in August 2024. This vaccine targets avian metapneumovirus (aMPV) type B and received approval from the U.S. Department of Agriculture (USDA) for both production and distribution. Developed collaboratively with Cambridge Technologies, this product is designed to counter the severe respiratory problems in poultry attributed to aMPV type B, which has been responsible for substantial economic losses since late 2023. Manufactured at a cutting-edge facility in Minnesota, the vaccine employs an oil and water emulsion formulation intended to reduce tissue reactions following vaccination, thus addressing a crucial market void given the prior absence of commercially licensed vaccines.
Veterinary Biologics Market Company Landscape And Competitive Strategy
Major companies operating in the veterinary biologics market are Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA, Indian Immunologicals Ltd., Vetoquinol, Beijing SVA Vaccines Serums
View The Full Veterinary Biologics Market Report:
Veterinary Biologics Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the veterinary biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
